Indraprastha Medical Corporation Ltd
Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]
- Market Cap ₹ 3,371 Cr.
- Current Price ₹ 368
- High / Low ₹ 641 / 342
- Stock P/E 18.4
- Book Value ₹ 80.8
- Dividend Yield 1.22 %
- ROCE 35.8 %
- ROE 27.5 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 132% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%
- Company has been maintaining a healthy dividend payout of 26.3%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE 1000 BSE Hospitals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 714 | 755 | 766 | 753 | 788 | 831 | 613 | 888 | 1,099 | 1,245 | 1,356 | 1,483 | |
| 630 | 675 | 686 | 678 | 706 | 743 | 572 | 768 | 947 | 1,050 | 1,112 | 1,216 | |
| Operating Profit | 85 | 80 | 79 | 74 | 82 | 87 | 41 | 120 | 152 | 195 | 245 | 267 |
| OPM % | 12% | 11% | 10% | 10% | 10% | 11% | 7% | 14% | 14% | 16% | 18% | 18% |
| 1 | 1 | -0 | -1 | -1 | -0 | -0 | -3 | 9 | 16 | 22 | 29 | |
| Interest | 8 | 7 | 8 | 9 | 7 | 6 | 3 | 3 | 4 | 4 | 6 | 6 |
| Depreciation | 28 | 35 | 31 | 31 | 30 | 33 | 33 | 35 | 39 | 40 | 44 | 44 |
| Profit before tax | 50 | 39 | 41 | 34 | 45 | 48 | 4 | 79 | 117 | 166 | 216 | 246 |
| Tax % | 34% | 37% | 36% | 38% | 36% | 9% | 46% | 26% | 26% | 25% | 26% | 25% |
| 32 | 24 | 26 | 21 | 28 | 44 | 2 | 59 | 86 | 124 | 161 | 184 | |
| EPS in Rs | 3.54 | 2.66 | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 13.52 | 17.56 | 20.03 |
| Dividend Payout % | 51% | 68% | 63% | 65% | 52% | 0% | 0% | 39% | 32% | 33% | 26% | 20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 19% |
| 3 Years: | 11% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 132% |
| 3 Years: | 28% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 37% |
| 3 Years: | 64% |
| 1 Year: | -16% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 27% |
| 3 Years: | 29% |
| Last Year: | 27% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 |
| Reserves | 103 | 132 | 139 | 141 | 152 | 176 | 181 | 234 | 288 | 386 | 505 | 649 |
| 50 | 52 | 67 | 66 | 21 | 4 | 3 | 5 | 2 | 34 | 33 | 37 | |
| 196 | 185 | 160 | 134 | 157 | 177 | 157 | 131 | 173 | 212 | 222 | 214 | |
| Total Liabilities | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 | 991 |
| 286 | 301 | 296 | 294 | 280 | 303 | 283 | 277 | 275 | 347 | 328 | 365 | |
| CWIP | 3 | 3 | 0 | 0 | 1 | 0 | 3 | 0 | 3 | 0 | 33 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 153 | 157 | 163 | 138 | 141 | 146 | 145 | 185 | 278 | 376 | 491 | 624 | |
| Total Assets | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 | 991 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64 | 62 | 28 | 48 | 75 | 86 | 27 | 94 | 144 | 200 | 157 | 167 | |
| -29 | -33 | -22 | -30 | -17 | -40 | -19 | -74 | -108 | -158 | -111 | -178 | |
| -35 | -30 | -5 | -17 | -44 | -43 | -3 | -3 | -26 | -32 | -46 | -46 | |
| Net Cash Flow | -0 | -0 | -0 | 1 | 14 | 4 | 5 | 17 | 11 | 9 | -0 | -57 |
| Free Cash Flow | 35 | 29 | 5 | 17 | 58 | 46 | 6 | 65 | 100 | 131 | 120 | 108 |
| CFO/OP | 98% | 104% | 57% | 82% | 110% | 113% | 88% | 95% | 102% | 127% | 89% | 88% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | 20 | 28 |
| Inventory Days | 11 | |||||||||||
| Days Payable | 182 | |||||||||||
| Cash Conversion Cycle | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | 20 | -144 |
| Working Capital Days | -35 | -22 | -17 | -7 | -5 | -10 | -1 | -2 | -12 | -24 | -19 | -4 |
| ROCE % | 23% | 18% | 17% | 15% | 19% | 21% | 3% | 29% | 34% | 38% | 39% | 36% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Average Revenue Per Occupied Bed (ARPOB) INR |
|
||||||||||
| In-patient Discharges Number |
|||||||||||
| Out-patient Volumes Number |
|||||||||||
| Average Length of Stay (ALOS) Days |
|||||||||||
| Average Bed Occupancy Percentage |
|||||||||||
| Operational Bed Capacity Number |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 May - We hereby submit copies of the public notice of the financial results, published on 13th May, 2026, in the "Financial Express", all India editions, in …
-
Board Meeting Outcome for OUTCOME OF THE BOARD MEETING
12 May - Company confirms it does not qualify as a Large Corporate under SEBI circulars.
-
Board Meeting Intimation for Audited Financial Results And Dividend
1 May - Board meeting on 12 May 2026 to approve FY26 audited results and consider dividend.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
23 Apr - Company confirms it is not a Large Corporate; outstanding borrowing was NIL as of 31 March 2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Apr - Please find herewith a certificate dated 1st April, 2026, issued by M/s MUFG Intime India Private Limited, Registrar & Transfer Agent of the Company, for …
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
JV of Apollo
IMCL is a JV between Apollo Hospital (22%) and the State Government of Delhi (26%), and has presence in the NCR with two facilities, a 718-bedded facility in Sarita Vihar (operational since 1996) and a 46-bedded facility in Noida (since 2006). [1]